Northern Capital Management (Washington)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Hold
238
0.12% 46
2026
Q1
$219K Hold
238
0.11% 51
2025
Q4
$256K Buy
+238
New +$228K 0.14% 42
2024
Q4
Sell
-238
Closed -$211K 43
2024
Q3
$211K Hold
238
0.13% 40
2024
Q2
$215K Buy
+238
New +$190K 0.14% 36
2023
Q4
Sell
-743
Closed -$399K 37
2023
Q3
$399K Hold
743
0.37% 24
2023
Q2
$348K Hold
743
0.26% 30
2023
Q1
$255K Hold
743
0.22% 35
2022
Q4
$272K Hold
743
0.26% 33
2022
Q3
$240K Hold
743
0.25% 31
2022
Q2
$241K Hold
743
0.23% 32
2022
Q1
$213K Hold
743
0.17% 40
2021
Q4
$205K Buy
+743
New +$188K 0.16% 44

Other funds holding LLY

Northern Capital Management (Washington)'s LLY Position: Q2 2026 in Review

Northern Capital Management (Washington) held its Eli Lilly (LLY) position steady in Q2 2026 at 238 shares worth $286K. The position accounts for 0.12% of the portfolio, ranked #46.

Northern Capital Management (Washington) first reported a position in LLY in Q4 2021 and has held it in 13 quarters since. The position peaked at $399K in Q3 2023. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Northern Capital Management (Washington) held 238 shares of Eli Lilly worth $286K as of Q2 2026.
  • Northern Capital Management (Washington) left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.12% of Northern Capital Management (Washington)'s portfolio in Q2 2026, its #46 holding.
  • Northern Capital Management (Washington) first reported a position in Eli Lilly in Q4 2021 and has held it in 13 quarters since.
  • Northern Capital Management (Washington)'s Eli Lilly position peaked at $399K in Q3 2023.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Northern Capital Management (Washington)'s 13F filing for Q2 2026, filed 21 Jul 2026.